This study describes attempts to increase and measure sensitivity of molecular tests to detect avian pneumovirus (APV). Polymerase chain reaction (PCR) diagnostic tests were designed for the detection of nucleic acid from an A-type APV genome. The objective was selection of PCR oligonucleotide combinations, which would provide the greatest test sensitivity and thereby enable optimal detection when used for later testing of field materials. Relative and absolute test sensitivities could be determined because of laboratory access to known quantities of purified full-length DNA copies of APV genome derived from the same A-type virus. Four new nested PCR tests were designed in the fusion (F) protein (2 tests), small hydrophobic (SH) protein (1 test), and nucleocapsid (N) protein (1 test) genes and compared with an established test in the attachment (G) protein gene. Known amounts of full-length APV genome were serially diluted 10-fold, and these dilutions were used as templates for the different tests. Sensitivities were found to differ between the tests, the most sensitive being the established G test, which proved able to detect 6,000 copies of the G gene. The G test contained predominantly pyrimidine residues at its 3Ј termini, and because of this, oligonucleotides for the most sensitive F test were modified to incorporate the same residue types at their 3Ј termini. This was found to increase sensitivity, so that after full 3Ј pyrimidine substitutions, the F test became able to detect 600 copies of the F gene.
Avian pneumovirus (APV) causes an upper respiratory tract infection in turkeys, leading to turkey rhinotracheitis, and in some other avian species, including chickens where it is also involved in the etiology of multifactorial diseases such as swollen head syndrome. The APVs were first reported from South Africa in the late 1970s. 3 Several years later the disease was observed in Europe where the causal agent was isolated 13, 19, 20 and characterized as a pneumovirus. 5, 7, 12 From that time the disease has been reported in most regions of the world and more recently in the United States. 17 The virus is now classified as the type strain of a new genus Metapneumovirus, 16 of which 4 subtypes (A, B, C, and D) have been recognized based on the nucleotide sequence differences. 8 The last subtype, referred to as D, includes 2 old French isolates. 1 Polymerase chain reaction (PCR) has been proved an invaluable tool in the detection of infectious agents since its inception in 1983. It has become possible to rapidly detect viral nucleic acid in a minimal time period, and amplified products can frequently be sequenced to provide more information about the etiological agent. This study considers the detection by PCR of APV, a virus that has frequently proved a difficult agent to detect by conventional isolation techniques. 8, 10 The application of PCR preceded by a reverse transcriptase (RT) step has led to increased levels of detection by several authors. 2, 6, 11, 14, 15, 18 Tests have been used to both detect and differentiate APVs using primers designed in matrix (M), attachment (G), fusion (F), and nucleocapsid (N) protein genes. However, it still frequently proves difficult to detect viral nucleic acid in situations where the virus has been indicated using retrospective serology. This is in part because of the viable virus being present for only a few days after infection, 4, 9 but it is nonetheless likely that improved test sensitivity would increase detection rates.
This article looks at several novel nested PCR tests within the F, N, and small hydrophobic (SH) protein genes of APV type A and compares their sensitivities with each other and with another established test designed in the APV attachment protein (G) gene. 14 To compare sensitivities between tests and to compare these test sensitivities with theoretical limits of sensitivity, known quantities of full-length DNA copies of the genome (13,373 bases) were used as DNA templates.
A European A-type APV was fully sequenced using short overlapping RT-PCR products covering the entire genome. To make a full-length genome copy, RNA from Vero cellpropagated virus was reverse transcribed in the leader, central, and trailer regions, and the complementary DNA (cDNA) generated was amplified by 3 long-distance PCRs. These products were cloned into pUC18-derived plasmids, and the excised inserts were ligated together and amplified in a single PCR to yield a full-length DNA copy of the virus. When the product was run on an ethidium bromide-stained gel, only 1 band of approximately 13,000 bp was visible. After spin column purification, the product concentration was determined on a further ethidium bromide-stained agarose gel containing a standard marker ladder, a and it was found to be 70 ng/l (0.7 ng/l ϭ 7 ϫ 10 Ϫ10 g/l). This was diluted 100 times for use as template for the later sensitivity testing of diagnostic PCRs. Oligonucleotides were designed and synthesized for use as primers for 4 nested PCRs in the N (test 1), 2 different regions of the F (tests 2 and 3), and SH (test 4) protein genes. Oligonucleotide design was based on having a purine base (G or C) at the 3Ј terminus. These tests were tested alongside a slightly modified version of an established attachment protein G (test 5) PCR, 6, 14 and all tests adopted the protocol of the latter. All oligonucleotide sequences are presented in Table 1 . Each nested PCR was tested at a range of DNA concentrations, which were prepared by 10-fold serial dilutions of the standard described above, with 1 l of each dilution being used as PCR template. Tests were performed simultaneously in the same PCR block to ensure standardization. Results of PCRs are presented in Table 2 , which shows detectability of DNA at a range of DNA template dilutions. These dilutions are described in terms of mass of DNA template in each PCR test. The established G test (number 5) was able to detect 7 ϫ 10 Ϫ14 g of DNA, whereas the other 4 tests (numbered 1-4) were 10 times less sensitive.
The sensitivity of the most sensitive test (G PCR, test 5) can be calculated in terms of numbers of copies of DNA as follows.
The number of base pairs per copy is 13,373. The mass of 1 mole would be ϭ 13,373 ϫ mass of 1 mole of base (500 g) ϭ 6.7 ϫ 10 6 g.
Hence, the number of moles detected ϭ (7 ϫ 10 Ϫ14 /6.7 ϫ 10 6 ) ϭ 1.04 ϫ 10 Ϫ20 .
Because 1 mole contains 6 ϫ 10 23 copies (Avogadro), the number of copies detected ϭ 6 ϫ 10 23 ϫ 1.04 ϫ 10 Ϫ20 ϭ 6,000.
It is sometimes assumed that PCR is able to detect a single copy of template DNA, but the sensitivity determined in this study was found to be 6,000 times lower than this theoretical maximum. The reasons for the G test giving the greatest sensitivity were not clear, but its continued use has been partly based on anecdotal evidence of good sensitivity compared with other tests during detection work with field material.
The oligonucleotides designed for the established G test had been constrained in their design by other overriding sequence considerations with respect to the APV A-and Btype sequences. However, it was noted that these oligonucleotides had a pyrimidine (A or T) at their 3Ј termini rather than purines, and it was speculated that this might play a role in their higher test sensitivity. One nested PCR in F (F4ϩ and F18Ϫ, test 3, Table 1 ) was selected to investigate this hypothesis. Table 3 shows how modified oligonucleotides were designed so that a minimal number of bases were added or removed to ensure a 3Ј pyrimidine terminus but without significantly changing the binding position or the annealing temperature. Input material from the first PCR (F19ϩ and F1Ϫ, test 3, Table 1 ) was used as template for 4 different internal PCRs (A, B, C, and D) , which used oligonucleotides with zero (A), one (F4ϩ or F18Ϫ; B or C), or two (F4ϩ and F18Ϫ; D) 3Ј pyrimidine termini. The changes were made sequentially, so that the unmodified oligonucleotides were tested and then substituted with first one, then two 3Ј pyrimidine oligonucleotides.
The results are shown in Table 3 . The unmodified test retained its initial sensitivity. The substitution of 3Ј pyrimidine terminal oligonucleotides led to a 10-fold sensitivity increase with each oligonucleotide substituted. By a calculation identical to that above, it was possible to show that the fully modified F test became capable of detecting 600 copies of the F gene.
PCR has proved an invaluable tool in the field of APV diagnostics. Before its introduction the only direct evidence of the infecting agent, as opposed to detection of an immune response, relied on virus isolation. The virus needed to be collected in field material during a very narrow time period, followed by its rapid transfer to susceptible avian tracheal organ cultures. In contrast, material for PCR can be conveniently stored at ambient temperatures, and positive detections of viral RNA can be made in material that was taken at a time beyond the loss of virus viability. The study described demonstrates a methodology to measure absolute sensitivities of such tests and explores ways of further improving their sensitivities. In this case a test in the F gene was modified, so that it exceeded the sensitivity of the established G gene test. It is interesting to note that a limited preliminary field study, undertaken by us, using the modified F PCR (both oligonucleotides 3Ј pyrimidine) after an RT step, showed an increased sensitivity compared with the es-tablished G test. Swab material from turkey tracheas was collected, and RNA was extracted. 6 After a RT reaction, 6 the cDNA was used in both G and F PCRs. In the future, this work will be expanded to determine whether the results remain valid in a larger study.
Some caution should be exercised with respect to assumptions about relative sensitivities in field testing. Extracted APV-derived RNA will include messenger RNA and genomic RNA, and the quantity of the former will depend on the level of transcription of the particular gene, as well as the amount of genomic RNA from which it derives. If a genomic (antisense) oligonucleotide is used in the RT step and the subsequent PCR is entirely within that gene, messenger RNA will be copied and amplified. Replacement with an antigenomic (sense) RT oligonucleotides will only lead to genomic RNA being amplified. When comparing the F and G PCRs, a higher transcription rate in G might offset any intrinsically higher F PCR sensitivity, but this would only become apparent if the genomic sense oligonucleotide was used in the RT stage. It would be interesting to follow up this study and compare the use of genomic and antigenomic RT oligonucleotides in RT-PCRs using RNA from APV-infected cells. This would give some measure of the relative amounts of these mRNAs in APV-infected cells, as well as moving closer to an even more sensitive diagnostic test.
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